Liquidia Corp Enters Material Definitive Agreement

TL;DR

Liquidia Corp signed a big deal on Sept 11, 2024. Details TBD.

AI Summary

On September 11, 2024, Liquidia Corporation entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement or any associated financial figures.

Why It Matters

This filing indicates a significant new development for Liquidia Corporation, potentially impacting its business operations and future strategies.

Risk Assessment

Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty about its nature and potential impact.

Key Players & Entities

• Liquidia Corporation (company) — Registrant

FAQ

Key Financial Figures

• $32.5 million — Fifth Amendment") to fund the remaining $32.5 million available under the Financing Agreement
• $32.5 m — ndment and the funding of the remaining $32.5 million, HCR will have funded a total of
• $67.5 million — illion, HCR will have funded a total of $67.5 million under the second tranche and each of th
• $23.8 million — to defer the one-time fixed payment of $23.8 million that was originally due on July 30, 202
• $50.0 million — pon the Company receiving not less than $50.0 million in aggregate gross proceeds from the sa
• $0.001 — f the Company's common stock, par value $0.001 per share, in one or more transactions
• $100.0 million — l have fully funded the entirety of the $100.0 million of the non-dilutive capital available t

Filing Documents

• tm2423751d1_8k.htm (8-K) — 28KB
• 0001104659-24-098781.txt ( ) — 198KB
• lqda-20240911.xsd (EX-101.SCH) — 3KB
• lqda-20240911_lab.xml (EX-101.LAB) — 33KB
• lqda-20240911_pre.xml (EX-101.PRE) — 22KB
• tm2423751d1_8k_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement . Fifth Amendment to Revenue Interest Financing Agreement As previously disclosed, on January 9, 2023, Liquidia Technologies, Inc., a Delaware corporation ("Liquidia Technologies") and a wholly owned subsidiary of Liquidia Corporation (the "Company") entered into a Revenue Interest Financing Agreement with HealthCare Royalty Partners IV, L.P. ("HCR"), as amended by that certain Amendment to Revenue Interest Financing Agreement, dated April 17, 2023, as amended by that certain Second Amendment to Revenue Interest Financing Agreement, dated June 28, 2023, as amended by that certain Third Amendment to Revenue Interest Financing Agreement, dated July 27, 2023, by and among Liquidia Technologies and HCR, and as further amended by that certain Fourth Amendment to Revenue Interest Financing Agreement, dated January 3, 2024 (as amended, the "Financing Agreement"). On September 11, 2024 (the "Effective Date"), Liquidia Technologies and HCR entered into a Fifth Amendment to the Financing Agreement (the "Fifth Amendment") to fund the remaining $32.5 million available under the Financing Agreement. The Fifth Amendment moves this additional $32.5 million from the third and fourth tranches to the second tranche, such that following the closing of the Fifth Amendment and the funding of the remaining $32.5 million, HCR will have funded a total of $67.5 million under the second tranche and each of the third and fourth tranches are eliminated. As a result, the payment schedule will remain a fixed payment schedule and will not in the future change to a tiered royalty on the Company's annual net revenue after the first commercial sale of YUTREPIA. As consideration for the additional invested amount, Liquidia Technologies has agreed to a modified fixed payment schedule that extends expected termination of payments under the Financing Agreement from 2029 to 2031. HCR has also agreed to defer the one-time fixed payment of $23.8 mil

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibit No. Exhibit 104 Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. September 11, 2024 Liquidia Corporation By: /s/ Michael Kaseta Name: Michael Kaseta Title: Chief Financial Officer and Chief Operating Officer